Reiteration of the Guidelines on Proper Management of Patients Started on Drug-Resistant TB (DR-TB) Treatment Experiencing Hepatotoxicity, Myelosuppression, Peripheral Neuropathy, and QTe Prolongation
- Version
- Download 76
- File Size 889.87 KB
- File Count 1
- Create Date June 5, 2020
- Last Updated January 27, 2023
Reiteration of the Guidelines on Proper Management of Patients Started on Drug-Resistant TB (DR-TB) Treatment Experiencing Hepatotoxicity, Myelosuppression, Peripheral Neuropathy, and QTe Prolongation
DM 2020-0257